Your session is about to expire
Hormone Blockers For Breast Cancer: What You Need To Know
Understanding Hormone Therapy and its Role in Hormone-Sensitive Cancers
Hormone therapy is a cancer treatment that slows or stops the growth of hormone-sensitive tumors, which require hormones to grow.
In some cases, hormone therapy removes hormones from the body. In other instances, it blocks their effects. Often, this therapy is used in combination with other treatments.
Different types of hormonal therapies are available for various cancers. For breast and prostate cancers, these treatments can be particularly effective, targeting estrogen in breast cancer and testosterone in prostate cancer.
Hormone therapies serve as an additional tool in cancer treatment strategies.
Risks, Side Effects, and Medicines Blocking Hormones
Medicines blocking hormones can cause side effects as these drugs alter how the body produces or uses hormones. The body relies on hormones for many functions, and side effects may occur.
Common side effects include:
- hot flashes
- fatigue
- mood swings
Less common but serious risks also exist, including:
- blood clots
- stroke
- endometrial cancer
Hormone-blocking medicines are available in different forms such as:
- pills
- injections
- implants
Each form has its own set of potential risks and side effects.
Understanding the benefits and risks involved in hormone-blocking therapy is crucial for health care management.
Find Top Cancer Clinical Trials
Choose from over 30,000 active clinical trials.
Reducing Estrogen with Aromatase Inhibitors and Halting Ovarian Function in Premenopausal Women
Estrogen fuels certain types of breast cancer. Aromatase inhibitors (AIs) lower estrogen levels and slow cancer growth by stopping the enzyme aromatase from turning other hormones into estrogen, a process known as "aromatization". Commonly used AIs include:
- anastrozole
- letrozole
- exemestane
For premenopausal women, halting ovarian function is crucial to reduce estrogen production. This can be achieved by surgery or drugs like goserelin or leuprolide, which suppress ovarian function temporarily. These methods are often combined with AI therapy for optimal results.
Clinical trials provide evidence about the effectiveness and safety profile of these treatments.
Combining Targeted Therapy with Hormones and Monitoring Treatment Outcomes
Targeted therapy and hormone treatments are two effective approaches in managing specific types of cancers. Combining these can enhance therapeutic outcomes. Targeted therapy works by focusing on the cancer's specific genes or proteins that contribute to its growth. Meanwhile, hormone treatment slows or stops cancer from growing by blocking the body's ability to produce hormones.
The combination of targeted therapy with hormones is a strategic approach. It allows for a more comprehensive attack on cancerous cells while preserving healthy ones. The effectiveness varies among patients due to individual genetic makeup and type of disease.
Monitoring treatment outcomes is crucial during this combined approach. Patients undergo regular tests like blood work and imaging scans to assess how well the treatment is working. These tests help detect changes in tumor size and check for any potential side effects early on.
Combining targeted therapy with hormonal treatments has shown promising results in fighting certain cancers effectively.